3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Terminated
2
Unknown
1
Suspended
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
310
Lymphoma
306
Lymphoma, Non-Hodgkin
227
Lymphoma, Large B-Cell, Diffuse
220
Lymphoma, Follicular
201
Leukemia, Lymphocytic, Chronic, B-Cell
168
Lymphoma, B-Cell
147
Recurrence
124
Burkitt Lymphoma
117
Lymphoma, Mantle-Cell
112
Leukemia, Myeloid, Acute
106
Leukemia
103
Hodgkin Disease
102
Multiple Myeloma
95
Lymphoma, B-Cell, Marginal Zone
87
Neoplasms
80
Myelodysplastic Syndromes
69
Lymphoma, T-Cell, Peripheral
62
Hematologic Neoplasms
61
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
58
Lymphoma, T-Cell
52
Lymphoma, T-Cell, Cutaneous
44
Waldenstrom Macroglobulinemia
41
Leukemia, Biphenotypic, Acute
35
Mycosis Fungoides
31
Lymphoproliferative Disorders
30
Leukemia, B-Cell
30
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
29
Breast Neoplasms
28
Myeloproliferative Disorders
26
Interventions
dolutegravir
1
Tenofovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
HTLV-I Infections
×
Lymphoid
×
Clear all
NCT07555431
2026-06-02
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Recruiting
146 enrolled